GUARDANT HEALTH INC GH
ASignal's systematic analysis rates GH as Neutral.
Reflects the latest available analysis · analyzed Aug 26, 2026
The case on GH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (44.3% YoY)
- High gross margin (65.01%) indicating pricing power
- MACD above signal line with positive histogram expansion
- Strong financial health score (0.9)
- High current and quick ratios (4.03x and 3.53x) indicating solid liquidity
- Negative profit and operating margins (-38.33% and -38.25%)
- Negative free cash flow trend ($-185.19M operating cash flow)
- Negative enterprise value to EBITDA (-52.90x) and price-to-book (-102.47x)
- Forward P/E of -386.39x indicates unprofitability
- No Reddit mentions, suggesting lack of retail investor interest
- Negative return on assets (-18.07%)
See the full verdict on GH
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes GH
Most investors never get a second opinion, let alone several. ASignal runs GH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.